NOVOZYMES A/S | 21,463 Euro | +0,072 +0,34 % | |
| WKN: A1JP9Y ISIN: DK0060336014 Ticker-Symbol: NZM2 | Frankfurt | 25.05.12 | 18:16 Uhr |
Branche BiotechnologieAktienmarkt OMX Copenhagen 20 |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 25.05. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 26 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 16.05. | Novozymes A/S: Share buyback program Novozymes A/S B shares | 36 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program Novozymes A/S B shares | ||||
| 15.05. | Novozymes Biopharma initiates production of hyaluronic acid | 2 | Pharma Bus Review | |
| 11.05. | Novozymes A/S: Share buyback program - Novozymes B shares | 19 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes B shares | ||||
| 10.05. | Novozymes A/S: Major Shareholder Announcement | 29 | GlobeNewswire | |
| In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co, together
with its wholly owned subsidiary Baillie... Mehr lesen zu: Novozymes A/S: Major Shareholder Announcement | ||||
| 07.05. | Novozymes A/S: Judge overturns jury's verdict in US patent law suit against Danisco and finds Novozymes' US Patent No. 7,713,723 invalid | 54 | GlobeNewswire | |
| In the US patent law suit concerning Novozymes' US Patent No. 7,713,723
covering certain alpha-amylase enzymes for use in the biofuel and starch
industries, Judge Barbara Crabb of the US District... Mehr lesen zu: Novozymes A/S: Judge overturns jury's verdict in US patent law suit against Danisco and finds Novozymes' US Patent No. 7,713,723 invalid | ||||
| 07.05. | Novozymes A/S: Major Shareholder Announcement | 43 | GlobeNewswire | |
| In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co (through
holdings in Baillie Gifford & Co, and through... Mehr lesen zu: Novozymes A/S: Major Shareholder Announcement | ||||
| 04.05. | Novozymes A/S: Major shareholder announcement | 38 | GlobeNewswire | |
| In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co (through
holdings in Baillie Gifford & Co, and through... Mehr lesen zu: Novozymes A/S: Major shareholder announcement | ||||
| 03.05. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 18 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 02.05. | Novozymes joins consortium to build biorefinery project in Denmark | 1 | Energy Bus Review | |
| 27.04. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 38 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 25.04. | Syngenta and Novozymes to partner for phosphate use efficiency | 30 | PR Newswire | |
| BASEL, Switzerland, April 25, 2012 /PRNewswire/ --
Exclusive expansion into new markets for JumpStart
Integrated offer with Seed Care
Sustainable solution for growers
Syngenta and Novozymes... Mehr lesen zu: Syngenta and Novozymes to partner for phosphate use efficiency | ||||
| 25.04. | Novozymes A/S: Group financial statement for the first quarter of 2012 | 30 | GlobeNewswire | |
| Sales growth and profitability in Q1 2012 as expected. Full-year outlook
maintained
Read the whole announcementAttachment:https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAt... Mehr lesen zu: Novozymes A/S: Group financial statement for the first quarter of 2012 | ||||
| 20.04. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 29 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 13.04. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 20 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 04.04. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 13 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 30.03. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 27 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 28.03. | BIO Announces Novozymes CEO and President Steen Riisgaard as its 2012 George Washington Carver Award Recipient | 68 | Business Wire | |
| BIO has named Steen Riisgaard as the recipient of its 2012 George
Washington Carver Award for innovation in industrial biotechnology.
A panel selected the... Mehr lesen zu: BIO Announces Novozymes CEO and President Steen Riisgaard as its 2012 George Washington Carver Award Recipient | ||||
| 23.03. | Novozymes A/S: Share buyback program - Novozymes A/S B shares | 42 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S B shares | ||||
| 16.03. | Novozymes A/S: Share buyback program - Novozymes A/S b shares | 28 | GlobeNewswire | |
| On January 20, 2012, Novozymes initiated a share buyback program in accordance
with the provisions of European Commission Regulation no. 2273/2003 of December
22, 2003, also referred to as the Safe... Mehr lesen zu: Novozymes A/S: Share buyback program - Novozymes A/S b shares | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| QIAGEN NV | 13,170 | +0,73 % | Qiagen - Weiteres Rallypotential bis ... |
| AGENNIX AG | 1,720 | +1,18 % | ERS: AGENNIX AG / 3-Monatsbericht 2012 |
| AMGEN INC | 54,55 | -0,89 % | Amgen Announces Voting Results Of Stockholders Meeting; CEO Kevin Sharer Retires |
| EVOTEC AG | 2,198 | +0,23 % | Evotec: Wichtige Hürde im Blickpunkt |
| CYTOS BIOTECHNOLOGY AG | 1,767 | +3,03 % | Cytos: Konstituierung des Verwaltungsrates |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
